Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal

T M Hohl1, M Feldmesser, D S Perlin

  • 1Infectious Diseases Service, Memorial Sloan-Kettering Cancer Center and Immunology Program, Sloan-Kettering Institute, New York 10021, USA. hohlt@mskcc.org

Insights

Echinocandins alter Aspergillus fumigatus morphology, increasing fungal beta-glucan exposure. This enhances Dectin-1-mediated inflammatory responses, impacting treatment strategies for invasive aspergillosis.

Area of Science:

  • Mycology
  • Immunology
  • Pharmacology

Background:

  • Echinocandins are antifungal drugs targeting beta-1,3 glucan synthesis.
  • They are used to treat invasive aspergillosis but do not fully inhibit Aspergillus fumigatus growth.
  • Beta-1,3 glucans are key fungal components that activate host immune responses via Dectin-1.

Purpose of the Study:

  • To investigate the impact of echinocandins on inflammatory responses to Aspergillus fumigatus.
  • To determine if echinocandin-induced morphological changes affect beta-glucan exposure and host immune cell activation.

Main Methods:

  • Treatment of Aspergillus fumigatus conidia and germlings with echinocandins (caspofungin, micafungin).
  • Co-incubation of treated and untreated fungal forms with macrophages.
  • Measurement of inflammatory cytokine secretion (TNF, CXCL2).
  • Assessment of beta-glucan exposure using antibody staining.

Main Results:

  • Echinocandin-treated conidia and germlings showed reduced TNF and CXCL2 secretion by macrophages, correlating with decreased beta-glucan exposure.
  • Echinocandin-treated hyphae induced increased TNF and CXCL2 release from macrophages.
  • Hyphal tips of echinocandin-treated fungi exhibited intense beta-glucan staining.

Conclusions:

  • Echinocandin treatment induces morphological changes in Aspergillus fumigatus hyphae, leading to increased beta-glucan exposure.
  • This increased exposure enhances Dectin-1-mediated inflammatory responses by macrophages.
  • Findings suggest a complex interplay between echinocandins, fungal morphology, and host immunity in aspergillosis treatment.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...